tirzepatide surpass-5

tirzepatide surpass-5 Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program | Cardiovascular Diabetology Latest Data From SURPASS Trials

Name: tirzepatide surpass-5 Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program | Cardiovascular Diabetology Latest Data From SURPASS Trials
Brand: actil.am
SKU: 30131593134
Price: 28.53 USD
Availability: InStock
Rating: 4.7389 (8 reviews)

SKU: 30131593134

4.7

USD28.53 USD67.53

Pay in 4 interest-free payments of $7.13 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

Description

The medication also delivers cardiovascular benefits independently of weight loss, including reduced heart attack and stroke risk in people with existing heart disease or diabetes